MAXCYTE, INC. (MXCT) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $6.22M | -12.4% |
| 2024 | $7.10M | +49.7% |
| 2023 | $4.74M | -7.0% |
| 2022 | $5.10M | +39.8% |
| 2021 | $3.65M | +31.8% |
| 2020 | $2.77M | +10.7% |
| 2019 | $2.50M | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $6.22M | -12.4% |
| 2024 | $7.10M | +49.7% |
| 2023 | $4.74M | -7.0% |
| 2022 | $5.10M | +39.8% |
| 2021 | $3.65M | +31.8% |
| 2020 | $2.77M | +10.7% |
| 2019 | $2.50M | — |